Source register
10 records
| Savara — MOLBREEVI (molgramostim inhalation solution) | Sponsor-reported goal date and indication; source dated 2026-11-09 |
| PolyPid — D-PLEX100 | Sponsor-reported goal date and indication; source dated 2026-11-11 |
| Corcept Therapeutics — Relacorilant | Sponsor-reported goal date and indication; source dated 2026-11-03 |
| Hansa Biopharma — Imlifidase | Sponsor-reported goal date and indication; source dated 2026-11-11 |
| Praxis Precision Medicines — Ulixacaltamide HCl | Sponsor-reported goal date and indication; source dated 2026-11-09 |
| Agios Pharmaceuticals — Mitapivat | Sponsor-reported goal date and indication; source dated 2026-11-05 |
| FDA — PDUFA VII | Program context and official review commitments |
| Synoptic SEC EDGAR stream | Confirmed SEC stream destination |
| Synoptic REST reference | Documented metadata and post interfaces |
| Synoptic MCP guide | Research access and permissions |
No matching records. Try a broader search.
The Synoptic workflow
Explore the Synoptic workflow
See how this topic connects to source-linked streams, APIs and research tools.
Explore the Synoptic workflow